Improving Muscle Health in Duchenne Muscular Dystrophy
Official title: The Role of Lipin1 in Myofiber Stability and Integrity
Funded at Wright State University · NIH-11092895 · Data updated 2026-11-12
This project explores how a protein called Lipin1 might help strengthen muscles and protect them from damage in Duchenne muscular dystrophy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wright State University NIH-funded |
| Lab location | 1 site (Dayton, United States) |
| Project start | July 22, 2021 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $321,893 |
| NIH project number | 5R01AR077574-05 |
| Project ID | NIH-11092895 on NIH RePORTER |
Who could benefit from this research
✓Could help
This foundational research is relevant for individuals living with Duchenne muscular dystrophy and their families.
✕Less likely to help
Patients without Duchenne muscular dystrophy would not directly benefit from this specific research focus.
What this research studies
Duchenne muscular dystrophy (DMD) causes severe muscle weakness and damage because a key protein, dystrophin, is missing, leading to fragile muscle cell membranes and muscle breakdown. Researchers are focusing on Lipin1, a protein found in muscles, which appears to be much lower in DMD patients and animal models. Early findings suggest that increasing Lipin1 levels in a mouse model of DMD helped reduce muscle damage, improve muscle cell strength, and significantly boost overall muscle strength. This work aims to understand how Lipin1 works and confirm if boosting its levels can improve muscle health in DMD.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that strengthen muscles and slow the progression of Duchenne muscular dystrophy.
How similar studies have gone: Preliminary data in mouse models of DMD have shown promising results, with increased Lipin1 levels leading to improved muscle strength and integrity.
Where this research is happening
-
Wright State University
Dayton, United States Active
Researchers
- Principal investigator: Ren, Hongmei — Wright State University
- Study coordinator: Ren, Hongmei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.